student currently based out of Los Angeles. The reason she decided to pursue photography full time is because she saw the impact pictures can … Continue reading →

Photo taken by Lisa, a licensed mental health counselor. She believes that we all need a creative outlet to help clear our heads of the occasional “gunk.” For her, it’s photography, and … Continue reading →

Photos taken by Rachel Bussières, a 26-year-old Quebec City, Canada native, currently based out of the North Coast of California. She has been connected to mental illness since her childhood, when … Continue reading →response, and toxic effects.  The ICOGEN results showed icotinib to have a median PFS of 4.6 months (95% CI 3.5 – 6.3) as compared to gefitinib which has a PFS of 3.4 months (95% CI 2.3 – 3.8).   After the study was completed, post-hoc analysis revealed that in the icotinib treatment group, patients with activating EGFR mutations showed improved PFS as compared to patients with wild-type EGFR.  Icotinib also was associated with fewer adverse events than gefitinib when considering all grades of reactions together (61% versus 70% respectively, p = 0.046).
The phase IV ISAFE trial evaluated 5,549 patients and showed icotinib to have an overall response rate of 30% and an adverse event rate of 31.5%. This trial demonstrated consistent safety and toxicity profiles